vonjo

Frequently asked questions

What does Vonjo treat?

Vonjo (Pacritinib Citrate) may be used to treat primary myelofibrosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How does Vonjo work?

Vonjo is a kinase inhibitor. Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.

Is there a coupon or discount for Vonjo?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vonjo. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Vonjo?

Vonjo is marketed by Sobi. You can see Sobi's full profile, rating, and other products on pharmaranks.

Is Vonjo a brand-name or generic drug?

Vonjo is a brand-name product with the active ingredient Pacritinib Citrate.

Is Vonjo available over the counter?

No. Vonjo is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Vonjo come in?

Vonjo is currently marketed as capsule, per the FDA's National Drug Code Directory.

What class of drug is Vonjo?

Vonjo is classified as kinase inhibitor, per the FDA's Established Pharmacologic Class.

Is Vonjo FDA-registered?

Vonjo is on record with the U.S. FDA under application number NDA208712. You can verify this on its official FDA label.